PL2663638T3 - Sposób hodowli w celu uzyskania i utrzymania czystej lub wzbogaconej populacji ssaczych nerwowych komórek macierzystych i/lub nerwowych komórek progenitorowych, które są podatne na różnicowanie w komórki linii oligodendrocytarnej in vitro - Google Patents

Sposób hodowli w celu uzyskania i utrzymania czystej lub wzbogaconej populacji ssaczych nerwowych komórek macierzystych i/lub nerwowych komórek progenitorowych, które są podatne na różnicowanie w komórki linii oligodendrocytarnej in vitro

Info

Publication number: PL2663638T3
Authority: PL; Poland
Prior art keywords: cells; oligodendrocyte; differentiate; prone; vitro
Prior art date: 2011-01-12

Application number

PL12701024T

Other languages

English (en)

Inventor

Tsuneo KIDO

Original Assignee

Oligogen Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-01-12

Filing date

2012-01-12

Publication date

2020-02-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45529155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2663638(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-01-12 Application filed by Oligogen Inc. filed Critical Oligogen Inc.

2020-02-28 Publication of PL2663638T3 publication Critical patent/PL2663638T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Zoology (AREA)
Neurology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Neurosurgery (AREA)
Cell Biology (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Developmental Biology & Embryology (AREA)
Ophthalmology & Optometry (AREA)
Psychology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Virology (AREA)

PL12701024T 2011-01-12 2012-01-12 Sposób hodowli w celu uzyskania i utrzymania czystej lub wzbogaconej populacji ssaczych nerwowych komórek macierzystych i/lub nerwowych komórek progenitorowych, które są podatne na różnicowanie w komórki linii oligodendrocytarnej in vitro PL2663638T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201161431944P	2011-01-12	2011-01-12
US201161558527P	2011-11-11	2011-11-11
PCT/IB2012/000030 WO2012095730A1 (en)	2011-01-12	2012-01-12	Culture method to obtain and maintain a pure or enriched population of mammalian neural stem cells and/or neural progenitor cells that are prone to differentiate into oligodendrocyte-lineage cells in vitro
EP12701024.7A EP2663638B1 (en)	2011-01-12	2012-01-12	Culture method to obtain and maintain a pure or enriched population of mammalian neural stem cells and/or neural progenitor cells that are prone to differentiate into oligodendrocyte-lineage cells in vitro

Publications (1)

Publication Number	Publication Date
PL2663638T3 true PL2663638T3 (pl)	2020-02-28

Family

ID=45529155

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL12701024T PL2663638T3 (pl)	2011-01-12	2012-01-12	Sposób hodowli w celu uzyskania i utrzymania czystej lub wzbogaconej populacji ssaczych nerwowych komórek macierzystych i/lub nerwowych komórek progenitorowych, które są podatne na różnicowanie w komórki linii oligodendrocytarnej in vitro

Country Status (21)

Country	Link
US (1)	US8993320B2 (pl)
EP (1)	EP2663638B1 (pl)
JP (1)	JP5649745B2 (pl)
KR (1)	KR102099807B1 (pl)
CN (2)	CN103687941A (pl)
AR (1)	AR084835A1 (pl)
AU (2)	AU2012206411B2 (pl)
BR (1)	BR112013017685A2 (pl)
CA (1)	CA2821065C (pl)
CL (1)	CL2013002029A1 (pl)
DK (1)	DK2663638T3 (pl)
EA (1)	EA034058B1 (pl)
ES (1)	ES2732938T3 (pl)
IL (1)	IL227361B (pl)
MX (1)	MX364742B (pl)
MY (1)	MY173219A (pl)
PH (1)	PH12013501496B1 (pl)
PL (1)	PL2663638T3 (pl)
SG (1)	SG191729A1 (pl)
TW (1)	TWI586805B (pl)
WO (1)	WO2012095730A1 (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1480521B1 (en)	2002-02-15	2015-02-25	Cornell Research Foundation, Inc.	Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
US9709553B2 (en)	2008-05-08	2017-07-18	University Of Rochester	Treating myelin diseases with optimized cell preparations
US10450546B2 (en)	2013-02-06	2019-10-22	University Of Rochester	Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
JP2016515403A (ja) *	2013-04-17	2016-05-30	ソークインスティテュートフォーバイオロジカルスタディーズ	ニューロン細胞培養のための培地組成物
JP6615616B2 (ja) *	2014-01-21	2019-12-04	国立研究開発法人科学技術振興機構	アダルト型オリゴデンドロサイト前駆細胞の製造方法
CN105154386B (zh) *	2014-05-30	2018-04-24	中国人民解放军第二军医大学东方肝胆外科医院	人肝细胞长期维持和增殖传代培养的专用培养基和培养方法
KR101675123B1 (ko) *	2014-06-27	2016-11-14	연세대학교 산학협력단	Psa-ncam-양성 신경전구세포를 유효성분으로 포함하는 허혈성 질환 또는 신경염증 질환 치료용 조성물
KR101793722B1 (ko)	2014-08-25	2017-11-03	한국생명공학연구원	성상세포의 생산방법
US20180037867A1 (en)	2015-03-04	2018-02-08	Mesoblast International Sàrl	Cell culture method for mesenchymal stem cells
EP3279318A4 (en) *	2015-03-30	2018-08-29	Ajinomoto Co., Inc.	Human serum albumin-containing culture medium for growth of neural stem cells
CA2982959C (en) *	2015-04-16	2021-08-31	The Board Of Regents, The University Of Texas System	Cd133+ cells and method for expanding
JP6844953B2 (ja) *	2015-04-22	2021-03-17	公益財団法人東京都医学総合研究所	アルツハイマー病研究を標的にしたグリア細胞システム
US9724432B2 (en)	2015-04-30	2017-08-08	University Of Rochester	Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
CN107921068A (zh) *	2015-06-26	2018-04-17	S生物医药公司	包含神经前体细胞的分泌蛋白质组作为有效成分的用于治疗缺血性疾病或神经炎症疾病的组合物
JP7018877B2 (ja) *	2015-08-15	2022-02-14	アステリアスバイオセラピューティクスインコーポレイテッド	白質卒中の治療のための幹細胞由来オリゴデンドロサイト前駆細胞
WO2017156762A1 (en)	2016-03-18	2017-09-21	Institute Of Biophysics, Chinese Academy Of Sciences	A cell culture medium and culture medium supplement
CN109219657A (zh)	2016-03-30	2019-01-15	阿斯特利亚斯生物治疗股份公司	少突胶质细胞祖细胞组合物
CN106929474B (zh) *	2017-03-31	2021-09-14	北京恒峰铭成生物科技有限公司	一种m2巨噬细胞诱导剂
EP3621434A4 (en)	2017-05-10	2021-03-31	University of Rochester	TREATMENT METHODS FOR NEUROPSYCHIATRIC DISORDERS
KR101889228B1 (ko) *	2017-09-29	2018-08-16	연세대학교 산학협력단	Psa-ncam-양성 신경전구세포를 유효성분으로 포함하는 척수손상 치료용 조성물
CN107760649B (zh) *	2017-11-02	2021-03-30	北京全式金生物技术有限公司	一种用于人神经系统细胞培养和人多能性干细胞向神经系统细胞分化的营养添加剂
CN108070558B (zh) *	2017-11-24	2022-01-28	吉林省拓华生物科技有限公司	一种临床级神经干细胞的制备方法
KR101994640B1 (ko)	2018-03-16	2019-07-02	(주)메디노	신경줄기세포의 고효율 분리배양 방법
JP2021521790A (ja) *	2018-04-17	2021-08-30	ケースウェスタンリザーブユニバーシティＣａｓｅＷｅｓｔｅｒｎＲｅｓｅｒｖｅＵｎｉｖｅｒｓｉｔｙ	ヒト皮質スフェロイドでのミエリン形成オリゴデンドロサイトの誘導
CN108624560B (zh) *	2018-06-01	2022-04-08	南京艾尔普再生医学科技有限公司	一种分化培养基及少突胶质前体细胞的制备方法
CA3113640A1 (en) *	2018-09-19	2020-03-26	Lineage Cell Therapeutics, Inc.	Methods for differentiating pluripotent stem cells in dynamic suspension culture
CA3127213A1 (en)	2019-01-23	2020-07-30	Asterias Biotherapeutics, Inc.	Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
WO2022005463A1 (en) *	2020-06-30	2022-01-06	National Yang-Ming University	A glia cell and neuron co-culture system and method
CN114540301B (zh) *	2020-11-20	2024-02-27	上海纽仁生物医药科技有限公司	少突胶质前体细胞亚群及其用途
KR20250007548A (ko)	2022-04-15	2025-01-14	아스펜 뉴로사이언스 인코포레이티드	세포의 분화 상태를 분류하는 방법 및 관련 분화된 세포 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990003430A1 (en) *	1988-09-23	1990-04-05	Cetus Corporation	Cell culture medium for enhanced cell growth, culture longevity and product expression
DE19756864C5 (de) *	1997-12-19	2014-07-10	Oliver Brüstle	Neurale Vorläuferzellen, Verfahren zu ihrer Herstellung und ihre Verwendung zur Therapie von neuralen Defekten
EP1263932A4 (en) *	2000-03-14	2004-06-23	Es Cell Int Pte Ltd	EMBRYONIC CELLS AND NEURONAL STEM CELLS DERIVED THEREFROM
IL152741A0 (en) *	2000-05-17	2003-06-24	Geron Corp	Neural progenitor cell populations
JP2004529621A (ja) *	2001-02-14	2004-09-30	ティーファークト，レオ	多能性成体幹細胞、その起源、それを得る方法および維持する方法、それを分化させる方法、その使用法、ならびにそれ由来の細胞
US9446073B2 (en) *	2005-05-15	2016-09-20	Biodontos, Llc	Non-lineage committed precursor cells from the dental papillary tissue of teeth
US20080153167A1 (en) *	2006-06-21	2008-06-26	The Trustees Of Columbia University In The City Of New York	In vivo amplification of neural progenitor cells
EP2089510B1 (en) *	2006-06-28	2021-02-24	The University of Medicine and Dentistry of New Jersey	Amnion-derived stem cells and uses thereof
US20110236971A2 (en) *	2007-09-25	2011-09-29	Maksym Vodyanyk	Generation of Clonal Mesenchymal Progenitors and Mesenchymal Stem Cell Lines Under Serum-Free Conditions
CN102325878A (zh) *	2008-12-23	2012-01-18	斯特姆塞尔思加利福尼亚有限公司	少突胶质前体细胞的靶向细胞群及制备与使用方法

2012
- 2012-01-12 MY MYPI2013701211A patent/MY173219A/en unknown
- 2012-01-12 DK DK12701024.7T patent/DK2663638T3/da active
- 2012-01-12 MX MX2013008208A patent/MX364742B/es active IP Right Grant
- 2012-01-12 AU AU2012206411A patent/AU2012206411B2/en active Active
- 2012-01-12 CN CN201280004915.9A patent/CN103687941A/zh active Pending
- 2012-01-12 TW TW101101245A patent/TWI586805B/zh active
- 2012-01-12 SG SG2013045810A patent/SG191729A1/en unknown
- 2012-01-12 EP EP12701024.7A patent/EP2663638B1/en active Active
- 2012-01-12 CN CN201811129309.5A patent/CN109749996A/zh active Pending
- 2012-01-12 AR ARP120100101A patent/AR084835A1/es not_active Application Discontinuation
- 2012-01-12 CA CA2821065A patent/CA2821065C/en active Active
- 2012-01-12 JP JP2013548899A patent/JP5649745B2/ja active Active
- 2012-01-12 BR BR112013017685A patent/BR112013017685A2/pt not_active Application Discontinuation
- 2012-01-12 ES ES12701024T patent/ES2732938T3/es active Active
- 2012-01-12 EA EA201390801A patent/EA034058B1/ru not_active IP Right Cessation
- 2012-01-12 PL PL12701024T patent/PL2663638T3/pl unknown
- 2012-01-12 WO PCT/IB2012/000030 patent/WO2012095730A1/en active Search and Examination
- 2012-01-12 US US13/349,089 patent/US8993320B2/en active Active
- 2012-01-12 PH PH1/2013/501496A patent/PH12013501496B1/en unknown
- 2012-01-12 KR KR1020137018381A patent/KR102099807B1/ko active Active
2013
- 2013-07-07 IL IL227361A patent/IL227361B/en active IP Right Grant
- 2013-07-12 CL CL2013002029A patent/CL2013002029A1/es unknown
2017
- 2017-08-18 AU AU2017216594A patent/AU2017216594B2/en active Active

Also Published As

Publication number	Publication date
MX2013008208A (es)	2013-10-17
NZ611902A (en)	2016-01-29
KR20140071512A (ko)	2014-06-11
IL227361A0 (en)	2013-09-30
PH12013501496A1 (pl)	2013-09-16
WO2012095730A1 (en)	2012-07-19
US20120177614A1 (en)	2012-07-12
TWI586805B (zh)	2017-06-11
BR112013017685A2 (pt)	2016-10-11
CL2013002029A1 (es)	2014-05-09
AU2017216594A1 (en)	2017-09-07
AR084835A1 (es)	2013-06-26
EA201390801A1 (ru)	2014-06-30
JP2014503219A (ja)	2014-02-13
CN109749996A (zh)	2019-05-14
EP2663638A1 (en)	2013-11-20
PH12013501496B1 (en)	2023-05-24
IL227361B (en)	2018-03-29
US8993320B2 (en)	2015-03-31
CA2821065A1 (en)	2012-07-19
AU2017216594B2 (en)	2020-01-23
ES2732938T3 (es)	2019-11-26
CA2821065C (en)	2021-05-18
AU2012206411B2 (en)	2017-05-18
DK2663638T3 (da)	2019-07-08
JP5649745B2 (ja)	2015-01-07
MX364742B (es)	2019-05-07
TW201237169A (en)	2012-09-16
CN103687941A (zh)	2014-03-26
SG191729A1 (en)	2013-08-30
KR102099807B1 (ko)	2020-04-14
EP2663638B1 (en)	2019-03-27
EA034058B1 (ru)	2019-12-23
MY173219A (en)	2020-01-07
NZ712598A (en)	2016-03-31
AU2012206411A1 (en)	2013-07-04

Publication	Publication Date	Title
IL227361A0 (en)	2013-09-30	A culture method for obtaining and maintaining a pure or enriched population of mammalian neural stem cells and/or neural progenitor cells that tend to differentiate into oligodendrocyte-lineage cells outside the body
PL3421601T3 (pl)	2020-06-01	Wytwarzanie i stosowanie zsyntetyzowanego in vitro ssRNA do wprowadzania do ssaczych komórek w celu indukcji efektu biologicznego lub biochemicznego
HRP20170269T1 (hr)	2017-04-07	Metode za proizvodnju glikoproteina u staničnim kulturama sisavaca koristeći glukokortikoide
EP2782996A4 (en)	2015-04-08	POPULATIONS OF HEMATOPOETIC PROCEDURES AND METHOD FOR ENRICHING STEM CELLS THEREFOR
BR112014030682A2 (pt)	2017-06-27	diferenciação de células tronco embrionárias humanas em células pancreáticas endócrinas
SG11201502183XA (en)	2015-05-28	In vitro pancreatic differentiation of pluripotent mammalian cells
SG10201610787XA (en)	2017-02-27	In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (pec) and endocrine cells
EP2891712A4 (en)	2016-04-06	METHOD FOR INDUCTING PLURIPOTENTAL STEM CELLS FOR DIFFERENTIATING VENTRICULAR IN MYOCYTES IN VITRO
EP2691512A4 (en)	2014-02-26	ENHANCED PULPATION OF HEART MUSCLE CELLS FROM PLURIPOTENTIAL STEM CELLS
IL227552A0 (en)	2013-09-30	Nucleic acid construct for expression of alpha-galactosidase in plant cells
EP2698365B8 (en)	2018-02-14	Synthesis and analysis of novel compound capable of inducing differentiation of human mesenchymal stem cell into hepatocyte
HK1221258A1 (zh)	2017-05-26	用於體外培養幹細胞的方法和培養基
EP2885403A4 (en)	2016-04-13	FAST METHOD FOR THE PRODUCTION OF HIGH-PURITY CANCER STEM CELLS AND HIGH-PURITY CANCER STEM CELL POPULATION
WO2011097242A3 (en)	2011-12-01	Methods of isolating and culturing mesenchymal stem cells
PL2524031T3 (pl)	2015-12-31	Linie ludzkich i mysich komórek macierzystych: modele śródbłonkowych komórek progenitorowych
IL225348A0 (en)	2013-06-27	A method for obtaining a cell population rich in desired cells
UA67620U (ru)	2012-02-27	Способ выделения мезенхимальных мультипотентных стромальных клеток